Literature DB >> 2738960

Therapeutic choices for the older hypertensive patient.

W B Applegate.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2738960      PMCID： PMC2625779     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN： 0027-9684            Impact factor:   1.798


× No keyword cloud information.
  8 in total

1.  Recruitment of elderly volunteers for a multicenter clinical trial: the SHEP pilot study.

Authors:  T M Vogt; C C Ireland; D Black; G Camel; G Hughes
Journal:  Control Clin Trials       Date:  1986-06

2.  Long-term surveillance for adverse effects of antihypertensive drugs.

Authors:  J D Curb; N O Borhani; T P Blaszkowski; N Zimbaldi; S Fotiu; W Williams
Journal:  JAMA       Date:  1985-06-14       Impact factor: 56.272

3.  Control of systolic blood pressure in elderly black patients.

Authors:  W B Applegate; R Vander Zwaag; S E Dismuke; J W Runyan
Journal:  J Am Geriatr Soc       Date:  1982-06       Impact factor: 5.562

4.  Labetalol in the treatment of hypertension in elderly and younger patients.

Authors:  D R Abernethy; P Bartos; J R Plachetka
Journal:  J Clin Pharmacol       Date:  1987-11       Impact factor: 3.126

5.  Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60.

Authors:  A Amery; W Birkenhäger; R Brixko; C Bulpitt; D Clement; M Deruyttere; A De Schaepdryver; C Dollery; R Fagard; F Forette
Journal:  Lancet       Date:  1986-09-13       Impact factor: 79.321

6.  Evolution of the clinical management of hypertension. Emerging role of "specific" vasodilators as initial therapy.

Authors:  V J Dzau
Journal:  Am J Med       Date:  1987-01-05       Impact factor: 4.965

7.  Hemodynamic effects of labetalol in young and older adult hypertensives.

Authors:  J C Buell; R S Eliot; J R Plachetka; M R Little
Journal:  J Clin Pharmacol       Date:  1988-04       Impact factor: 3.126

8.  Systolic Hypertension in the Elderly Program (SHEP): antihypertensive efficacy of chlorthalidone.

Authors:  S B Hulley; C D Furberg; B Gurland; R McDonald; H M Perry; H W Schnaper; J A Schoenberger; W M Smith; T M Vogt
Journal:  Am J Cardiol       Date:  1985-12-01       Impact factor: 2.778
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.